MétaCan
Menu
← Back to cohort
Record W4409624317 · doi:10.1158/1538-7445.am2025-902

Abstract 902: Examining the impact of chromosome 1q-located gamma secretase subunits in the resistance to BCMA-targeted therapies in multiple myeloma patients

2025· article· en· W4409624317 on OpenAlexaff
Sejal Chikhale, Mansour Poorebrahim, Holly Lee, Elham Hasheminasabgorji, Anja Barbour, David Jung, Paola Neri, Nizar J. Bahlis

Bibliographic record

VenueCancer Research · 2025
Typearticle
Languageen
FieldMedicine
TopicMultiple Myeloma Research and Treatments
Canadian institutionsUniversity of Calgary
Fundersnot available
KeywordsGamma secretaseMultiple myelomaCancer researchMedicineChromosomeGeneticsInternal medicineOncologyBiologyGene

Abstract

fetched live from OpenAlex

Abstract Multiple Myeloma (MM) is an incurable hematological malignancy originating from abnormal plasma cells in the bone marrow. A common genetic abnormality in MM is the gain or amplification of chromosome arm 1q (chr1q), present in 30-40% of MM patients and typically associated with poor prognosis. Chr1q includes three subunits of the gamma-secretase (GS) enzyme- Nicastrin (NCSTN), Presenilin-2 (PS2), and Anterior Pharynx Defective 1 Homolog A (APH1A)—which catalyze the conversion of membrane-bound BCMA (mBCMA) to soluble BCMA (sBCMA). BCMA is a crucial target receptor for anti-BCMA therapies. Elevated sBCMA levels are linked to poor prognosis and reduced efficacy of BCMA-targeted therapies, apparently due to the sink effect. We hypothesize that chr1q amplification in MM leads to increased GS expression, resulting in reduced mBCMA and elevated sBCMA levels, which may drive resistance to BCMA-targeted therapies and contribute to adverse patient outcomes. To investigate this, we employed cloning and lentiviral transduction techniques to overexpress NCSTN, PS2, and APH1A individually, as well as in various combinations, in OPM2 myeloma cell lines, generating seven novel cell lines. Each subunit was fused with distinct tags to confirm successful transduction and overexpression. Using flow cytometry with BCMA-PE antibodies and sBCMA ELISA, we assessed mBCMA and sBCMA levels across these GS subunit-overexpressing cell lines compared to an empty vector control. Our results demonstrated that all seven GS subunit-overexpressing OPM2 cell lines exhibited decreased mBCMA levels. The triple-overexpressing cell line (NCSTN, PS2, and APH1A) showed a remarkable ten-fold reduction in mBCMA compared to the control. Additionally, differences in sBCMA levels were observed across the GS subunit-overexpressing cell lines relative to the control. These findings underscore the pivotal role of GS subunits encoded by chr1q in driving the poor prognosis associated with chr1q gain or amplification in MM. Ongoing analyses aim to elucidate the resistance mechanisms of these GS subunit-overexpressing OPM2 cell lines to anti-BCMA CAR-T therapies and T-cell engagers (TCEs). Citation Format: Sejal Chikhale, Mansour Poorebrahim, Holly Lee, Elham Hasheminasabgorji, Anja Barbour, David Jung, Paola Neri, Nizar J. Bahlis. Examining the impact of chromosome 1q-located gamma secretase subunits in the resistance to BCMA-targeted therapies in multiple myeloma patients [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 902.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.094
GPT teacher head0.411
Teacher spread0.317 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer Research→Same topicMultiple Myeloma Research and Treatments→French-language works237,207→